drugset / Trial / NCT03318094

Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity

NCT03318094

Phase 1 Active not recruiting 36 enrolled Vanderbilt University Medical Center
RandomizedCrossoverSingle-blindBasic science

Summary

The purpose of this study is to better understand the contribution of sympathetic vasoconstriction to impaired insulin-mediated vasodilation and subsequently insulin-mediated glucose uptake. The investigators will test the hypothesis that removal of sympathetic vasoconstriction can result in improvement in insulin-mediated vasodilation and subsequently sensitivity to insulin-mediated glucose uptake.

Timeline

Start
2017-10-24
Primary completion
2026-11-30
Completion
2027-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Phentolamine Small molecule Other
Comparator Sodium Nitroprusside Unknown Other

Indications